PET/CT and breast cancer
- PMID: 20880780
- PMCID: PMC2967130
- DOI: 10.1102/1470-7330.2010.9031
PET/CT and breast cancer
Abstract
This paper summarises the current status of PET/CT in relation to breast cancer.
References
-
- American Cancer Society. Breast cancer overview. http://www.cancer.org/Cancer/BreastCancer/OverviewGuide/index; 2010.
-
- Townsend DW. Dual-modality imaging: combining anatomy and function. J Nucl Med. 2008;49:938–55. doi:10.2967/jnumed.108.051276. PMid:18483101. - DOI - PubMed
-
- Avril N, Rose CA, Schelling M, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol. 2000;18:3495–502. - PubMed
-
- Shimoda W, Hayashi M, Murakami K, Oyama T, Sunagawa M. The relationship between FDG uptake in PET scans and biological behavior in breast cancer. Breast Cancer. 2007;14:260–8. doi:10.2325/jbcs.14.260. PMid:17690502. - DOI - PubMed
-
- Ikenaga N, Otomo N, Toyofuku A, et al. Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors. Am Surg. 2007;73:1151–7. - PubMed